Farmacovigilancia - Pharmacological Surveillance
Download as PPTX, PDF
3 likes264 views
Clinical trials for several drugs including Tamiflu, Tamsulosin, Dabigatran, Agomelatine, and Liraglutide were found to have high percentages of unpublished results on ClinicalTrials.gov. A study found Tamiflu trials were 51% unpublished, Tamsulosin over 75% unpublished, and Dabigatran over 80% unpublished, raising concerns about incomplete dissemination of clinical trial data.
Farmacovigilancia - Pharmacological Surveillance
- 28. (%)
- 29. 檎艶壊艶岳
- 36. Tamiflu (Oseltamivir): Unpublished ClinicalTrials.gov Records => 51% (23 out of 45) Tamsulosin >75% unpublished Dabigatran >80% unpublished Agomelatine >80% unpublished Liraglutide: 68.5% - three times as likely to be disseminated (3.1 to be spec
- 37. Re: Concerns over data in key dabigatran trial. http://www.bmj.com/content/349/bmj.g4747/rr/778288 October 17, 2014.